ARGOLYN BIOSCIENCE, INC.

Address

ARGOLYN BIOSCIENCE, INC.
2750 Speissegger Drive, Suite 110
NORTH CHARLESTON, SC, -

Information

DUNS:
# of Employees: N/A

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. Development of Neurotensin-based Analgesics

    Amount: $163,945.00

    DESCRIPTION (provided by applicant): Chronic, neuropathic pain is one of the most important unmet medical needs in the United States, affecting tens to hundreds of millions of people nationwide at som ...

    SBIRPhase I2006Department of Health and Human Services
  2. Novel Neurotensin Analogs as Antischizophrenics

    Amount: $3,000,000.00

    DESCRIPTION (provided by applicant): This is the follow-on Phase II SBIR proposal to continue the project Novel Neurotensin Analogs as Antischizophrenics (MH-65099) under PA-06-079 (Pharmacological ...

    SBIRPhase II2005Department of Health and Human Services
  3. NON-NATURAL AMINO ACIDS IN PEPTIDE DRUG DEVELOPMENT

    Amount: $125,279.00

    Argolyn Bioscience Inc. is an early stage biotechnology company that creates novel peptide drugs and diagnostics with greatly improved intrinsic pharmaceutical properties through substitution of non-n ...

    STTRPhase I2002Department of Health and Human Services
  4. NOVEL NEUROTENSIN ANALOGS AS ANTISCHIZOPRENICS

    Amount: $139,466.00

    DESCRIPTION (provided by applicant): The brain peptide neurotensin (NT) and its active derivative NT [8-13] function as endogenous neuroleptics. Stable NT derivatives that cross the blood brain barrie ...

    STTRPhase I2002Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government